<?xml version="1.0" encoding="UTF-8"?>
<fig id="fig8">
 <label>Fig. 8</label>
 <caption>
  <p>Predicted viral dynamics under treatment. (A) The efficacy of antiviral drug is assumed to be 
   <inline-formula>
    <math id="d1e241" display="inline" altimg="si77.svg">
     <mrow>
      <mi>ε</mi>
      <mo linebreak="goodbreak" linebreakstyle="after">=</mo>
      <mn>0</mn>
      <mo>.</mo>
      <mn>6</mn>
     </mrow>
    </math>
   </inline-formula> and (B) 
   <inline-formula>
    <math id="d1e255" display="inline" altimg="si78.svg">
     <mrow>
      <mi>ε</mi>
      <mo linebreak="goodbreak" linebreakstyle="after">=</mo>
      <mn>0</mn>
      <mo>.</mo>
      <mn>9</mn>
     </mrow>
    </math>
   </inline-formula>. We performed simulation using the fit to the LRT viral load data of patient #2 in 
   <xref rid="b14" ref-type="bibr">[14]</xref>, 
   <xref rid="b54" ref-type="bibr">[54]</xref> as an example. The treatment is assumed to be administrated on day 10, 15 and 20, respectively; (C) For comparison with (A) and (B), the value of 
   <inline-formula>
    <math id="d1e274" display="inline" altimg="si24.svg">
     <mi>ω</mi>
    </math>
   </inline-formula> is increased by 5 folds to represent IFN intensification. The antiviral drug efficacy is the same as that in (A), i.e. 
   <inline-formula>
    <math id="d1e279" display="inline" altimg="si77.svg">
     <mrow>
      <mi>ε</mi>
      <mo linebreak="goodbreak" linebreakstyle="after">=</mo>
      <mn>0</mn>
      <mo>.</mo>
      <mn>6</mn>
     </mrow>
    </math>
   </inline-formula>; (D) Predicted dynamics under anti-inflammation therapy. The value of 
   <inline-formula>
    <math id="d1e293" display="inline" altimg="si22.svg">
     <mi>λ</mi>
    </math>
   </inline-formula> is fixed to be 10
   <sup>4</sup>, 10
   <sup>3</sup>, 10
   <sup>2</sup> and 10 cells ml
   <sup>−1</sup> day
   <sup>−1</sup>, respectively.
  </p>
 </caption>
 <graphic xlink:href="gr8_lrg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
